Evidence map›Paper›PMID 34395408›Full record

ArticleFrontiers in bioengineering and biotechnology2021

Improving the Production of Riboflavin by Introducing a Mutant Ribulose 5-Phosphate 3-Epimerase Gene in

Bin Yang, Yiwen Sun, Shouying Fu, Miaomiao Xia, Yuan Su, Chuan Liu, Chunzhi Zhang, Dawei Zhang

Open access · greenAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 8 citations in OpenAlex.

  1. Enhanced production of l-histidine inSynthetic and systems biotechnology · 2026
    Article
  2. Engineering riboflavin-overproducingSynthetic and systems biotechnology · 2026
    Article
  3. Review
  4. Metabolic Engineering Strategy forFoods (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Metabolic Engineering ofMicroorganisms · 2023
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Bin YangSchool of Biological Engineering, Dalian Polytechnic University, Dalian, China.
Yiwen SunSchool of Biological Engineering, Dalian Polytechnic University, Dalian, China.
Shouying FuTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
Miaomiao XiaTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
Yuan SuTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
Chuan LiuTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
Chunzhi ZhangSchool of Biological Engineering, Dalian Polytechnic University, Dalian, China.
Dawei ZhangTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, China.
Tianjin University of Science and Technology · CNChinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ribulose 5-phosphate (Ru5P) and guanosine 5'-triphosphate (GTP) are two key precursors of riboflavin, whereby Ru5P is also a precursor of GTP. Ribulose 5-phosphate 3-epimerase (Rpe) catalyzes the conversion of ribulose 5-phosphate into xylulose 5-phosphate. Inactivation of Rpe can reduce the consumption of Ru5P, enhancing the carbon flux toward riboflavin biosynthesis. Here we investigated the effect of mutation of

Indexed as

Bacillus subtilispentose phosphate pathwayriboflavinribulose 5-phosphate 3-epimerasetruncated protein

Identifiers

PMID34395408
PMCPMC8359813
OpenAlexW3139459788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.